GHK-Cu (Copper Peptide)

Loren Pickart and the GHK Research Programme

UKPWritten & reviewed by The UK Peptides Editorial Team · Research library, UK Peptides2 min readLast reviewed 2026-08-234 cited sources

The short answer

Loren Pickart isolated GHK in 1973 and has authored or co-authored a substantial share of the literature since, including the 2008 tissue remodelling review, the 2012 oxidative stress paper and the 2015 gene expression analysis. That concentration is worth knowing when weighing the evidence.

Key facts

Isolated GHK
1973
Key reviews
2008, 2012, 2015, 2017
2008
J Biomater Sci Polym Ed (PMID 18644225)
2012
Oxid Med Cell Longev (PMID 22666519)
2015
Biomed Res Int (PMID 26236730)
2017
Brain Sci (PMID 28212278)
Consideration
Concentrated authorship in the evidence base

The body of work

Pickart's involvement spans the original isolation through to recent reviews. The 2008 paper in the Journal of Biomaterials Science addressed tissue remodelling; the 2012 paper in Oxidative Medicine and Cellular Longevity addressed oxidative stress and degenerative conditions; the 2015 paper with Margolina in BioMed Research International reported the gene-expression analysis; the 2017 paper in Brain Sciences examined gene expression relevant to the nervous system.

Why sustained single-investigator work is valuable

Depth. Someone who has worked on a molecule for decades knows its chemistry, its failure modes and its history in a way a newcomer does not. Long programmes produce coherent bodies of work and preserve institutional knowledge that would otherwise be lost between generations of researchers.

Research material referenced

GHK-Cu 100mg, third-party HPLC tested

Buy GHK-Cu · £24.99

And why it matters

Independent replication is how findings become established. When a substantial share of a literature originates from one group, the evidence is less independent than the paper count suggests. That is not because of any impropriety, but because shared methods, assumptions and reagents propagate through it. This is a standard consideration in evidence appraisal and applies to any concentrated literature.

What that means practically

Findings replicated by unconnected groups carry more weight than those from a single programme, however extensive. For GHK-Cu, the copper-binding chemistry is independently established and not in doubt. The broader claims about gene expression and ageing rest on a narrower base, and authorship should be checked when assessing how independent a given citation is.

Reading the reviews

Several of the most-cited GHK sources are reviews rather than primary research. A review by the investigator who discovered the compound is a useful synthesis and an interested one. It is the right place to start and the wrong place to stop, and following its primary citations is the way to see what the underlying data actually shows.

Frequently asked questions

Who is Loren Pickart?
The researcher who isolated GHK from human plasma in 1973 and has authored much of the subsequent literature, including several widely cited reviews.
Does concentrated authorship make the work unreliable?
No. It means the evidence is less independent than the paper count implies, which is a standard consideration in appraising any literature.
Which findings are independently established?
The copper-binding chemistry is not in doubt. The broader claims about gene expression and ageing rest on a narrower base.

Extended research context

The GHK-Cu (Copper Peptide) deep dive

Deep dive: why the copper ion matters

The GHK tripeptide (Gly-His-Lys) coordinates a Cu²⁺ ion through the imidazole nitrogen of histidine, the terminal α-amino group of glycine, and a deprotonated peptide-bond nitrogen. This near-square-planar geometry is what gives the complex its characteristic deep-blue colour and its redox-modulating chemistry. Uncomplexed GHK is a different molecule pharmacologically. Nearly every peer-reviewed study attributes activity to the copper-bound form, which is why suppliers ship the pre-complexed GHK-Cu rather than plain GHK.

GHK-Cu in the transcriptomic literature

The most-cited modern papers on GHK-Cu come from the Pickart & Margolina group and independent transcriptomic re-analyses. GHK-Cu has been reported to modulate expression of >4,000 human genes at nanomolar concentrations in Broad Institute Connectivity Map re-analyses, including genes involved in DNA repair, antioxidant defence, and ECM remodelling. This gene-signature-level activity is the reason GHK-Cu appears in so many research reviews outside of dermatology.

Analytical fingerprinting of GHK-Cu

On reverse-phase HPLC, GHK-Cu elutes as a well-defined peak; free GHK and copper-free peptide impurities are distinguishable. UV-Vis at ~520 nm confirms the copper d-d transition band. Reputable suppliers publish both HPLC (≥98% area) and mass-spec identity (~340 Da complex, 340.4 free peptide) on the batch CoA.

Research applications

  • ▸In vitro fibroblast and keratinocyte gene-expression studies
  • ▸ECM turnover assays (collagen, elastin, decorin, MMP profiling)
  • ▸Wound-healing scratch assays in cell culture models
  • ▸Antioxidant-mechanism studies (copper redox modulation)
  • ▸Formulation R&D: cosmetic and topical carrier compatibility research

Handling checklist

  • ✓Store lyophilised vial at 2–8 °C, protected from light
  • ✓Reconstitute with bacteriostatic or sterile water; expect a blue-tinted solution
  • ✓Avoid contact with reducing agents (ascorbic acid destabilises Cu²⁺)
  • ✓Aliquot reconstituted solution for freeze/thaw minimisation
  • ✓Verify blue colour and CoA HPLC ≥98% before use

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Buying GHK without copper

Fix: Confirm the CoA reads GHK-Cu (copper-bound); free GHK is a different pharmacology.

✗ Mixing with vitamin C in solution

Fix: Ascorbate reduces Cu²⁺ to Cu⁺ and destabilises the complex, keep them separate.

✗ Exposing to sunlight

Fix: Store in amber vial or foil-wrapped container at 2–8 °C.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Related questions researchers ask

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

UKP

Written and reviewed by

The UK Peptides Editorial Team · Research library, UK Peptides

The editorial team is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate. Corrections are made in place and the review date updated.

More GHK-Cu (Copper Peptide) articles

Popular across the research hub

One flagship guide from every other research category.

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.